The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia

BACKGROUND: The drug hydroxychloroquine (HCQ) is widely used to treat rheumatoid arthritis (RA) and has been repurposed for the treatment of COVID-19. This study aims to determine whether HCQ concentration levels in individuals with RA alter the incidence of COVID-19 or its complications. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Walbi, Ismail A., Alqhtani, Hussain, Alqahtani, Faleh, Alkahtani, Saad Ahmed, Mohamed Alshabi, Ali, Alali, Amer S., Albarqi, Hassan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124633/
https://www.ncbi.nlm.nih.gov/pubmed/35645589
http://dx.doi.org/10.1016/j.jsps.2022.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124633/
https://www.ncbi.nlm.nih.gov/pubmed/35645589
http://dx.doi.org/10.1016/j.jsps.2022.05.006

Ejemplares similares